Moreover, the results of multivariate logistic regression analysis showed that cefepime Cmin ≥ 87.765 mg/l was associated with a fivefold increase in the risk of CPZ-induced coagulopathy in patients. The gene discussed is CPZ; the disease is blood coagulation disease.